| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |